跳至主要内容
临床试验/DRKS00009669
DRKS00009669已完成未知

Clinical Pilot study to investigate safety of Collagen Matrix 10808 in combination with a Coronally Advanced Flap (CAF) in the treatment of single tooth gingival recession -

Geistlich Pharma AG0 个研究点目标入组 10 人开始时间: 2015年11月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Signed informed consent with given ample time
  • 2. Age 18 years or older
  • 3. Recession defects are Miller Class I-II at incisors, canines or premolars
  • 4. Recession size of > 3mm
  • 5. Presence of at least 1 mm keratinized tissue around the target tooth
  • 6. Full-Mouth Plaque score < 25% (O'Leary, Drake et al. 1972)
  • 7. Patients with healthy or effectually treated periodontal conditions

排除标准

  • 1.General contraindications for dental and/or surgical treatments
  • 2.Concurrent or previous immunosuppressant, bisphosphonate or high dose corticosteroid therapy
  • 3.Inflammatory and autoimmune disease of oral cavity
  • 4.History of myeloma, respiratory tract cancer, breast cancer, prostate cancer or kidney cancer requiring chemotherapy or radiotherapy within the past five years
  • 5.Radiotherapy of head area
  • 6.Disease or condition affecting connective tissue metabolism (e.g. disease of arteries in the operating zone, bone metabolic diseases, alcohol abuse, treatment with anticoagulants)
  • 7.Any systemic diseases that affect bone metabolism (e.g thyroid dysfunction, autoimmune disease)
  • 8.Untreated acute periodontal disease
  • 9.Smokers (zero cigarettes allowed per day)
  • 10.Diabetes
  • 11.Pregnant or lactating women
  • 12.Women of child bearing age, not using a highly effective method of birth control
  • 13.Allergy to collagen
  • 14.Participation in an investigational device, - drug or biologic study within the last 24 weeks prior to the study start

研究者

相似试验